P2Y12 inhibitor monotherapy 1 to 3 mo after PCI did not differ from standard DAPT for fatal or ischemic events.
Where this comes from
- Record sourced from PubMed, PMID 37276597.
- Also identified by DOI 10.7326/J23-0032.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gragnano F, Mehran R, Branca M; Single Versus Dual Antiplatelet Therapy (Sidney-2) Collaboration. <b>P2Y<sub>12</sub> inhibitor monotherapy or dual antiplatelet therapy after complex percutaneous coronary interventions.</b> J Am Coll Cardiol. 2023;81:537-552. 36754514.
Medical subject headings
- Platelet Aggregation Inhibitors
- Percutaneous Coronary Intervention